High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease

PLoS Currents

Volumn , Issue JUL, 2013, Pages

  Balci, Fuat ^a   Oakeshott, Stephen ^b   Shamy, Jul Lea ^c   El Khodor, Bassem F ^d   Filippov, Igor ^b   Mushlin, Richard ^b   Port, Russell ^b   Connor, David ^b   Paintdakhi, Ahmad ^b   Menalled, Liliana ^b   Ramboz, Sylvie ^b   Howland, David ^e   Kwak, Seung ^e   Brunner, Dani ^b,f  

^a KOÇ UNIVERSITY   (Turkey)

^b PSYCHOGENICS INC   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d PFIZER INC   (United States)

^e CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^f Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CIRCADIAN RHYTHM; COGNITION; CONTROLLED STUDY; FEMALE; GENOTYPE; HABITUATION; HIGH THROUGHPUT SEQUENCING; HUNTINGTON CHOREA; LICKING; LIGHT DARK CYCLE; LIGHT INTENSITY; LOCOMOTION; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REVERSAL REACTION; SCORING SYSTEM;

EID: 84881514117     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.hd.124aa0d16753f88215776fba102ceb29     Document Type: Article

References (35)

1. Maggi S, Luciana G, Heise I, Nieus T, Balci{dotless} F, Wells S, Tocchini-Valentini GP, Mandillo S, Nolan PM, Tucci V. A cross-laboratory investigation of timing endophenotypes in mouse behavior. Timing & Time Perception. in press.
2. Lipp, H.-P. (2005). High-throughput and Automated Behavioural Screening of Normal and Genetically Modified Mice, Business Briefing: Future Drug Discovery.
3. Gallistel CR, King AP, Daniel AM, Freestone D, Papachristos EB, Balci F, Kheifets A, Zhang J, Su X, Schiff G, Kourtev H. Screening for Learning and Memory Mutations: A New Approach. Xin Li Xue Bao. 2010 Jan 30;42(1):138-158. PubMed PMID:20352069. 20352069.
4. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008 Jun 11;28(24):6182-95. PubMed PMID:18550760. 18550760.
5. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet. 1997 Feb;15(2):197-200. PubMed PMID:9020849. 9020849.
6. Ciamei A, Morton AJ. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease. Neurobiol Learn Mem. 2008 May;89(4):533-44. PubMed PMID:18069020. 18069020.
7. Ciamei A, Morton AJ. Rigidity in social and emotional memory in the R6/2 mouse model of Huntington's disease. Neurobiol Learn Mem. 2008 May;89(4):533-44. PubMed PMID:18069020. 18069020.
8. Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci. 1999 Dec 1;19(23):10428-37. PubMed PMID:10575040. 10575040.
9. Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis. 2009 Sep;35(3):319-36. PubMed PMID:19464370. 19464370.
10. Morton AJ, Skillings E, Bussey TJ, Saksida LM. Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system. Nat Methods. 2006 Oct;3(10):767. PubMed PMID:16990806. 16990806.
11. Pallier PN, Maywood ES, Zheng Z, Chesham JE, Inyushkin AN, Dyball R, Hastings MH, Morton AJ. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci. 2007 Jul 18;27(29):7869-78. PubMed PMID:17634381. 17634381.
12. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci. 1999 Apr 15;19(8):3248-57. PubMed PMID:10191337. 10191337.
13. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005 Jan 5;25(1):157-63. PubMed PMID:15634777. 15634777.
14. Oakeshott S, Port RG, Cummins-Sutphen J, Watson-Johnson J, Ramboz S, Park L, Howland D, Brunner D. HD mouse models reveal clear deficits in learning to perform a simple instrumental response. PLoS Curr. 2011a Nov 30;3:RRN1282. PubMed PMID:22512000. 22512000.
15. Balci F, Day M, Rooney A, Brunner D. Disrupted temporal control in the R6/2 mouse model of Huntington's disease. Behav Neurosci. 2009 Dec;123(6):1353-8. PubMed PMID:20001119. 20001119.
16. Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Bartlett PF, Hannan AJ. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci. 2005 Oct;22(8):2081-8. PubMed PMID:16262645. 16262645.
17. Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci. 2000 Jul 1;20(13):5115-23. PubMed PMID:10864968. 10864968.
18. Cepeda C, Ariano MA, Calvert CR, Flores-Hernández J, Chandler SH, Leavitt BR, Hayden MR, Levine MS. NMDA receptor function in mouse models of Huntington disease. J Neurosci Res. 2001 Nov 15;66(4):525-39. PubMed PMID:11746372. 11746372.
19. Cepeda C, Hurst RS, Calvert CR, Hernández-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci. 2003 Feb 1;23(3):961-9. PubMed PMID:12574425. 12574425.
20. Abada YS, Schreiber R, Ellenbroek B. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease. Behav Brain Res. 2013 Feb 1;238:243-51. PubMed PMID:23123142. 23123142.
21. Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, Colwell CS. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease. Exp Neurol. 2011 Mar;228(1):80-90. PubMed PMID:21184755. 21184755.
22. Morton AJ, Lagan MA, Skepper JN, Dunnett SB. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation. J Neurocytol. 2000 Sep;29(9):679-702. PubMed PMID:11353291. 11353291.
23. NRC (1996) Guide for the care and use of laboratory animals. National Academy, Washington, DC.
24. Jacobs GH, Fenwick JC, Calderone JB, Deeb SS. Human cone pigment expressed in transgenic mice yields altered vision. J Neurosci. 1999 Apr 15;19(8):3258-65. PubMed PMID:10191338. 10191338.
25. Rudenko O, Tkach V, Berezin V, Bock E. Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage. Behav Brain Res. 2009 Nov 5;203(2):188-99. PubMed PMID:19410605. 19410605.
26. Bäckman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain. 1997 Dec;120 (Pt 12):2207-17. PubMed PMID:9448576. 9448576.
27. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry. 1995 May;58(5):598-606. PubMed PMID:7745410. 7745410.
28. Lawrence AD, Sahakian BJ, Rogers RD, Hodge JR, Robbins TW. Discrimination, reversal, and shift learning in Huntington's disease: mechanisms of impaired response selection. Neuropsychologia. 1999 Nov;37(12):1359-74. PubMed PMID:10606011. 10606011.
29. Oscar-Berman M, Zola-Morgan SM, Oberg RG, Bonner RT. Comparative neuropsychology and Korsakoff's syndrome. III--Delayed response, delayed alternation and DRL performance. Neuropsychologia. 1982;20(2):187-202. PubMed PMID:6211634. 6211634.
30. Oakeshott S, Port RG, Cummins-Sutphen J, Watson-Johnson J, Ramboz S, Park L, Howland D, Brunner D. HD mouse models reveal clear deficits in learning to perform a simple instrumental response. PLoS Curr. 2011 Nov 30;3:RRN1282. PubMed PMID:22512000. 22512000.
31. Oakeshott S, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Paterson N, Kwak S, Howland D, Brunner D. A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington's disease. PLOS Currents Huntington Disease. 2012 Apr 25 [last modified: 2012 Sep 4]. Edition 1. doi: 10.1371/4f972cffe82c0.
32. Wood NI, Goodman AO, van der Burg JM, Gazeau V, Brundin P, Björkqvist M, Petersén A, Tabrizi SJ, Barker RA, Morton AJ. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Res Bull. 2008 May 15;76(1-2):70-9. PubMed PMID:18395613. 18395613.
33. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008 Jun 11;28(24):6182-95. PubMed PMID:18550760. 18550760.
34. Hostetter, R. (1966). Time of day effects on learning and open field activity. Psychon. Sci., 5, 257-258.
35. Valentinuzzi VS, Buxton OM, Chang AM, Scarbrough K, Ferrari EA, Takahashi JS, Turek FW. Locomotor response to an open field during C57BL/6J active and inactive phases: differences dependent on conditions of illumination. Physiol Behav. 2000 May;69(3):269-75. PubMed PMID:10869592. 10869592.